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Voltage-gated ion channels exhibit complex proper-
ties, which can be targeted in pharmacological
therapies for disease. Here, we report that the pro-
oxidant, tert-butyl dihydroquinone (BHQ), modulates
Cav2.1 Ca
2+ channels in ways that oppose defects in
channel gating and synaptic transmission resulting
from a familial hemiplegic migraine mutation
(S218L). BHQ slows deactivation, inhibits voltage-
dependent activation, and potentiates Ca2+-depen-
dent facilitation of Cav2.1 channels in transfected
HEK293T cells. These actions of BHQ help offset
the gain of function and reduced Ca2+-dependent
facilitation of Cav2.1 channels with the S218L muta-
tion. Transgenic expression of the mutant channels
at the Drosophila neuromuscular junction causes
abnormally elevated evoked postsynaptic potentials
and impaired synaptic plasticity, which are largely
restored to the wild-type phenotypes by BHQ. Our
results reveal a mechanism by which a Cav2.1 gating
modifier can ameliorate defects associated with a
disease-causing mutation in Cav2.1.
INTRODUCTION
Voltage-gated Cav2.1 Ca
2+ channels mediate P/Q-type Ca2+
currents that control neuronal excitability and neurotransmitter
release throughout the nervous system (Catterall, 2000). The
neurophysiological requirement for Cav2.1 is illustrated by the
severe ataxia, dyskinesia, and absence epilepsy in mice lacking
Cav2.1 (Jun et al., 1999; Maejima et al., 2013; Mark et al., 2011).
In addition, human mutations in the CACNA1A gene encoding
the pore-forming a1 subunit of Cav2.1 (a12.1) cause multiple
neurological disorders, including episodic ataxia (Ophoff et al.,
1996), spinocerebellar ataxia (Zhuchenko et al., 1997), and famil-
ial hemiplegic migraine (FHM1) (Ophoff et al., 1996).
Among Cav channels, Cav2.1 exhibits particularly complex
behavior and modulation. Single Cav2.1 channels can alternatebetween gating modes characterized by distinct kinetics and
voltage-dependent activation (Fellin et al., 2004; Luvisetto
et al., 2004). In addition, Cav2.1 channels undergo both positive
and negative feedback regulation by Ca2+, Ca2+-dependent
facilitation (CDF), and Ca2+-dependent inactivation (CDI),
respectively, which contributes to short-term synaptic plasticity
(Catterall and Few, 2008; Christel and Lee, 2012). While dihydro-
pyridine analogs have greatly advanced understanding of Cav1
channel gating in normal and diseased states (Erxleben et al.,
2006; Nowycky et al., 1985), the scarcity of pharmacological
modulators for Cav2.1 limits similar mechanistic insights for
these channels.
2,50-di(tertbutyl)-1,4,-benzohydroquinone (BHQ) is a synthetic
phenolic compound that inhibits sarcoendoplasmic Ca2+ ATP-
ases (SERCAs) (Moore et al., 1987) and has pro-oxidant pro-
perties (Fusi et al., 1999). Here, we report that, independent of
these actions, BHQ inhibits Cav2.1 voltage-dependent activation
and enhances CDF during high-frequency stimuli. These actions
of BHQ ameliorate gating defects in Cav2.1 and synaptic trans-
mission due to a S218L mutation in a12.1 that causes a severe
form of FHM1 in humans (Kors et al., 2001). Our results reveal
unique features of Cav2.1 gating that may be exploited for ther-
apeutic benefit.
RESULTS
BHQ Inhibits Cav2.1 Activation and Slows Deactivation
During studies to evaluate the effect of intracellular Ca2+ on
Cav2.1 in transfected human embryonic kidney cells trans-
formed with SV40 T-antigen (HEK293T) cells, we discovered
modulatory actions of BHQ onCav2.1 properties. BHQ reversibly
inhibited Cav2.1 Ba
2+ currents (IBa) in a dose-dependent manner
(half-maximal inhibitory concentration [IC50] of 7.9 ± 1.0 mM;
Figures 1A–1C) and across a range of voltages (Figures 1D and
1E). To determine the underlying mechanism, we analyzed tail
currents, which are evoked by the repolarization-induced
change in driving force and reflect the population of open chan-
nels at the end of the test depolarization. BHQ suppressed tail
currents most strongly at moderate voltages (Figure S1 available
online), which indicated a voltage-dependent mechanism of
inhibition rather than a pore-blocking effect. Two-componentNeuron 81, 91–102, January 8, 2014 ª2014 Elsevier Inc. 91
Figure 1. BHQ Inhibits Voltage-Dependent Activation of Cav2.1
(A–C) Dose-response properties. (A) Representative IBa evoked by a 30ms test pulse to +10mV from80mV before (Control), during (+BHQ), and after (Washout;
trace is partially obscured due to full reversal of the effect of BHQ). bath perfusion with BHQ (10 mM). (B) Same as in (A) except that the cell was exposed to the
indicated concentrations of BHQ (in mM, gray traces). (C) Dose-response curve for BHQ inhibition of IBa evoked as in (A). Smooth line in (C) represents fit by the Hill
equation, n = 8 cells.
(D–G) Effects of BHQ on IBa. (D) Representative IBa evoked by a 15 ms test pulse to +10 mV from80 mV before (Control) and during perfusion with BHQ (+BHQ,
10 mM). (E) Current-voltage relationship. IBa was evoked by 15-ms steps from80mV to various voltages with repolarization to40mV to facilitate measurement
of tail currents in (F). IBa amplitudes were normalized to cell capacitance and plotted against voltage, n = 9 cells. (F) Normalized (Norm.) tail current-voltage plots
obtained from data in (E). Peak tail current amplitudes were normalized to that obtained with a +85 mV test pulse. Smooth lines represent fits by a double-
Boltzmann function. (G) Voltage dependence of BHQ inhibition of the steady-state current measured at the end of the test depolarization (Test IBa) and tail current
measured upon repolarization to40 mV (Tail IBa). Test IBa and tail IBa recorded in the presence of BHQ were expressed as the percentage of the corresponding
values under control conditions and plotted against test voltage. nA= nanoamperes; pA/pF = picoamperes/picofarads.
(H–K) Effects of BHQ on ICa. Same as in (D) through (G), except for ICa. In (H), test pulse (to +20 mV) was 50 ms to achieve steady-state ICa. In (J), smooth lines
represent fits by a single-Boltzmann (for Control) or double-Boltzmann (+BHQ) function; n = 7 cells. All averaged data represent mean ± SEM.
See also Figure S1.
Neuron
Modulation of Cav2.1 Gating by BHQBoltzmann analysis revealed that the normalized tail current-
voltage curves with BHQ were positively shifted and had a
more shallow slope than controls, with BHQ enhancing the
component (fraction = F) of IBa activating at positive voltages
(F2; Figure 1F; Table 1). BHQ reduced tail currents to a similar
extent and with similar voltage dependence as the steady-state
current (Figure 1G), which indicated that BHQ inhibits Cav2.1
currents primarily by modifying voltage-dependent activation.
These effects of BHQ were generally similar for Ca2+ currents
(ICa; Figures 1H–1K). However, unlike IBa, tail currents for ICa92 Neuron 81, 91–102, January 8, 2014 ª2014 Elsevier Inc.were best fit by a single Boltzmann function under control condi-
tions and exhibited maximal amplitudes at intermediate volt-
ages. This latter feature has been attributed to CDF, which is
particularly prominent for Cav2.1 (Chaudhuri et al., 2007). BHQ
introduced a second high-threshold component to the activation
curve (Figure 1J; Table 1). These results demonstrate that BHQ
inhibits voltage-dependent activation of Cav2.1 and has distinct
actions on IBa and ICa.
Although BHQ can raise intracellular Ca2+ due to SERCA
blockade (Moore et al., 1987), a structurally distinct SERCA
Table 1. Parameters for Voltage-Dependent Activation
Parameters
Values Obtained Before
(Control) and After BHQ (+BHQ) p Value
WT IBa (n = 10) Control
a +BHQa
Vh1 7.1 ± 1.1 mV 0.2 ± 0.8 mV <0.001
k1 3.9 ± 0.3 6.6 ± 0.2 <0.001
F1 0.65 ± 0.02 0.49 ± 0.01 <0.001
Vh2 10.4 ± 1.7 mV 26.7 ± 1.2 mV <0.001
k2 9.3 ± 0.5 13.3 ± 0.4 <0.001
F2 0.35 ± 0.02 0.51 ± 0.01 <0.001
WT ICa (n = 7) Control
b +BHQa
Vh1 0.0 ± 1.6 mV 3.3 ± 3.1 mV 0.21
k1 6.3 ± 0.5 5.6 ± 0.1 0.17
F1 1.0 0.69 ± 0.03 0.02
Vh2 – 28.0 ± 2.5 mV –
k2 – 5.8 ± 1.2 –
F2 – 0.29 ± 0.04 –
S218L IBa (n = 12) Control
a +BHQa
Vh1 14.5 ± 0.9 mV 12.5 ± 1.2 mV 0.08
k1 5.8 ± 0.1 6.9 ± 0.2 <0.001
F1 0.60 ± 0.01 0.42 ± 0.02 <0.001
Vh2 11.7 ± 1.6 mV 23.6 ± 1.4 mV <0.001
k2 12.5 ± 0.3 16.6 ± 0.5 <0.001
F2 0.38 ± 0.01 0.56 ± 0.02 <0.001
S218L ICa (n = 7) Control
b +BHQa
Vh1 6.8 ± 1.7 mV 8.7 ± 1.9 mV 0.19
k1 7.2 ± 0.7 6.2 ± 0.4 0.27
F1 1.0 0.50 ± 0.02 <0.001
Vh2 – 17.0 ± 4.1 mV –
k2 – 13.8 ± 0.8 –
F2 – 0.49 ± 0.03 –
Normalized tail current-voltage relationships were fit with either a single
or a double Boltzmann function. The p values were determined by paired
t test. Vh1 and Vh2 indicate half-maximal activation; k1 and k2 indicate
slope factors; F1 and F2 indicate fractional current.
aDouble Boltzmann function.
bSingle Boltzmann function.
Figure 2. Effects of BHQ on Cav2.1 Are Independent of SERCA
Inhibition
(A) Same as in Figures 1H–1J except that ICa was evoked by a 30-ms test pulse
before (Control) and after (+THP) bath application of thapsigargin (10 mM).
Points represent mean ± SEM; n = 10 cells. Norm., normalized.
(B and C) Representative traces showing the effects of BHQ on [Ca2+]i in
HEK293T cells transfected with Cav2.1 cDNAs; n = 27 cells in (B), and n = 6
cells in (C). Each trace represents an individual cell. In (B), cells were loaded
with Fura-2/AM and subject to Ca2+ imaging. In (C), Ca2+ imaging was con-
ducted on cells that were subject to the same whole-cell patch-clamp
recording conditions as in (A), except that the intracellular recording solution
contained 100 mMFura-2. F340/F380, fluorescence ratio where F340 and F380 are
fluorescence intensities at the excitation wavelengths 340 and 380 nm,
respectively.
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Modulation of Cav2.1 Gating by BHQinhibitor, thapsigargin, had no effect on Cav2.1 properties (Fig-
ure 2A). BHQ was capable of modestly increasing intracellular
Ca2+ in intact HEK293T cells transfected with Cav2.1, as indi-
cated by the ratiometric Ca2+ indicator, Fura-2 (Figure 2B). How-
ever, under our whole-cell recording conditions, which included
5 mM EGTA in the intracellular recording solution, BHQ did not
produce any change in the level of intracellular Ca2+ (Figure 2C).
Therefore, the modulatory effects of BHQ on Cav2.1 are inde-
pendent of SERCA antagonism.
In addition to inhibiting Cav2.1 activation, BHQ caused a
prominent slowing of deactivation that was evident as a prolon-
gation of the tail currents. For ICa, the dominant effects of BHQ
were a significant increase in the fraction and time constant of
a slow component of deactivation (Figure 3A). To better under-
stand the modulatory effects of BHQ on inhibiting activation
and slowing deactivation, we developed a ten-state model (Fig-ure S2). According to the model, despite slower deactivation,
decreased open probability of channels modulated by BHQ at
moderate test voltages would cause the decline in steady-state
current amplitude with BHQ (Figure S2). Consistent with the
model, the proportion of whole-cell ICa that was inhibited by
BHQ was identical to the fraction of the slow tail ICa across a
range of test voltages (Figure S2; p = 1.0, by two-way ANOVA).
We conclude that BHQ stabilizes the opening and weakens
voltage-dependent activation of Cav2.1, which causes slower
tail currents and a reduction in the steady-state current,
respectively.
BHQ Enhances Ca2+-Dependent Facilitation Induced by
Action Potential Waveforms
Double exponential fits of the tail current decay revealed a sig-
nificantly larger effect of BHQ on ICa compared to IBa. From
this analysis, there was no difference in the amplitudes of the
slow and fast components (Aslow and Afast, respectively) for tail
ICa and tail IBa, but the slow time constant for tail ICa decay
(6.7 ± 0.8 ms) was significantly greater than that for IBa (4.8 ±
0.4 ms, p = 0.03; Figure 3B). The more prominent effect of
BHQ on deactivation of ICa was particularly apparent in plots of
the slow tail current amplitude measured 5 ms after repolariza-
tion to the holding voltage. At this time point, the current ampli-
tude should be practically devoid of the contribution of the
rapidly decaying tail current resulting largely from channelsNeuron 81, 91–102, January 8, 2014 ª2014 Elsevier Inc. 93
Figure 3. BHQ-Modulated Cav2.1 Channels Exhibit Slow Deactiva-
tion that Is Greater for ICa than for IBa
(A) ICa was evoked by 15-ms test pulses from 80 mV to various voltages with
repolarization to 40 mV under control conditions or in the presence of BHQ
(10 mM). Representative current traces are shown (left). For +20 mV to40 mV
step, the decay of tail currents was fit with a double exponential function.
Averaged data (mean ± SEM; right) represent the time constant (t) and frac-
tional contribution (Fraction) of the fast and slow component. *p < 0.01 by
paired t test.
(B) Representative traces for IBa (left) were evoked as in (A). Averaged data
(mean ± SEM; right) show fast and slow time constants from double expo-
nential fits of the decay of tail IBa (for +10 mV to 40 mV step, n = 10) and ICa
(n = 7) in the presence of BHQ. *p = 0.03 by t test.
(C) For ICa and IBa evoked as in (A) and (B), tail current amplitudes were
measured 5 ms following the repolarization to40mV and plotted against test
voltage. The percent increase caused by BHQ is indicated for ICa (at +20 mV)
and IBa (at +10 mV). Points represent mean ± SEM.
See also Figure S2.
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Modulation of Cav2.1 Gating by BHQthat are not modulated by BHQ. By this metric, BHQ had nearly
double the effect in prolonging tail ICa compared to tail IBa
(Figure 3C).
The stronger effects of BHQ on deactivation of ICa compared
to IBa suggested the potential for BHQ to enhance CDF of
Cav2.1 currents during trains of action potential waveforms
(APWs). Due to the short duration (half-width, <1 ms) of APWs
and relatively slow activation kinetics of Cav2.1, APWs do not
evoke significant ICa during the depolarizing phase but produce
large tail currents upon repolarization. During trains of APWs, ICa
undergoes both voltage-dependent facilitation (VDF) (Brody and
Yue, 2000; Currie and Fox, 2002) and CDF due to Ca2+/calmod-
ulin (Benton and Raman, 2009; Chaudhuri et al., 2007; Kreiner
et al., 2010). In contrast, IBa exhibits primarily VDF. Because
CDF and VDF occur on similar time scales, net CDF is measured
as the fractional increase (FCDF) in the amplitude of ICa over IBa at94 Neuron 81, 91–102, January 8, 2014 ª2014 Elsevier Inc.the end of a train of APWs (Figures 4A–4D). With this protocol,
CDF results in an increase in ICa (Chaudhuri et al., 2007), which
may be further amplified by BHQ.
To test this, we analyzed the effect of BHQ on ICa and IBa
during trains of APWs. To restrict analysis to CDF in the absence
of the competing effects of CDI, the whole-cell intracellular
recording solution contained 5mMEGTA, which blunts CDI (Fig-
ure S3) but spares CDF (Lee et al., 2000). With this protocol, CDF
was significantly greater with BHQ (FCDF = 0.25 ± 0.02) than
without BHQ (FCDF = 0.17 ± 0.02, p = 0.04; Figures 4B–4D). To
more clearly discern the effect of BHQ on ICa and IBa, currents
recorded after exposure to BHQwere normalized to themaximal
amplitude of the current before bath perfusion with BHQ (i.e., at
0.3 s; FBHQ in Figure 4E). By this measure, BHQ inhibited IBa but
clearly increased ICa (Figure 4E). The inhibition of IBa was not due
to an effect of BHQ on voltage-dependent inactivation, since
BHQ did not enhance the decay of IBa evoked by a sustained
depolarization (Figure S3). When CDF was prevented by coex-
pression of a calmodulin (CaM) mutant (DeMaria et al., 2001;
Lee et al., 2003), ICa was not maintained to control levels in the
presence of BHQ (Figure S3). Taken together, these results
show that BHQ inhibits VDF but also increases CaM-dependent
CDF during physiological stimuli.
BHQ Offsets Gain of Function of Cav2.1 due to FHM1
Mutation
The S218L mutation enhances voltage-dependent activation of
Cav2.1, which augments excitatory transmission in S218L
knockin (KI) mice (Tottene et al., 2005; van den Maagdenberg
et al., 2004, 2010). However, S218L also inhibits CDF, which is
associated with impaired synaptic plasticity (Adams et al.,
2010). The dual effects of BHQ on inhibiting voltage-dependent
activation and enhancing CDF suggested that it could oppose
dysfunction associated with the S218L FHM1 mutation in
a12.1. To test this, we analyzed the effect of BHQ on ICa and
IBa in HEK293T cells transfected with S218L-containing chan-
nels. As shown elsewhere (Tottene et al., 2005), IBa for S218L
cells exhibits more negative voltage dependence of activation
than wild-type (WT) Cav2.1 (Figures 5A and 5B; Table 1). Reduc-
tions in current density seen with S218L compared to WT (Fig-
ure 5A) may be an artifact of heterologous overexpression, as
this is not observed for Cav2.1 currents in neurons from KI
mice expressing S218L channels (Pietrobon, 2010). BHQ had
similar effects on S218L as on WT channels in inhibiting current
density and voltage-dependent activation of IBa and ICa (Figures
5C–5H; Table 1). Across a physiological voltage range (30 mV
to 10 mV), BHQ offset the enhancement of IBa caused by the
S218L mutation by 25%–44% (Figure S4). Therefore, BHQ re-
duces the gain of function in Cav2.1 caused by S218L.
BHQ Restores CDF Loss of Function due to FHM1
Mutation
Similar to its effects on WT channels, BHQ slowed deactivation
of S218L (Figures 6A and 6B). However, this effect of BHQ
was greater for S218L than for WT (Figures 6C and 6D).
Compared to WT channels, BHQ caused a more dramatic shift
in the balance of fast and slow fractions of S218L tail ICa decay,
such that total decay was dominated by the slow fraction
Figure 4. BHQ Enhances CDF
(A) Voltage protocol for APWs (200 Hz) and representative ICa and
IBa recorded before (control) and after (+BHQ) bath perfusion with BHQ
(10 mM).
(B and C) Peak current amplitudes of ICa or IBa were normalized to the first in
the series (Inorm.) and plotted against time. Points represent mean ± SEM.
Dashed lines indicate initial Inorm.
(D) CDF was measured as the difference in Inorm. for ICa and the mean Inorm. for
IBa at 0.3 s (FCDF; mean ± SEM). *p = 0.001 by t test.
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Modulation of Cav2.1 Gating by BHQ(0.58 ± 0.02 for S218L versus 0.42 ± 0.05 for WT; p = 0.01 by
t test; Figure 6D). The slow fraction of ICa decay under control
conditions was twice as large for S218L compared to WT
(0.16 ± 0.03 for S218L versus 0.08 ± 0.01 for WT, p = 0.03; Fig-
ure 6D). BHQ also increased the slow time constant of ICa decay
for S218L (tslow = 5.3 ± 0.8ms for control versus 10.2 ± 0.7ms for
BHQ) as it did forWT channels (Figures 6B and 6D). These results
suggested that BHQ stabilizes a fraction of slowly deactivating
channels, which are more prevalent in S218L than WT.
To determine whether BHQ could restore CDF to S218L, we
compared ICa and IBa evoked by trains of APWs (Figures 7A–
7C). Because the S218L mutation accelerates fast voltage-
dependent inactivation of ICa and IBa (Tottene et al., 2005; Weiss
et al., 2008), IBa progressively decreased during the train (Fig-
ure 7B). For this reason, we evaluated ICa and IBa during
100 ms trains as opposed to the 300 ms trains used for WT
channels (Figure 4). As shown elsewhere (Adams et al., 2010),
S218L did not undergo as much CDF as WT (FCDF = 0.09 ±
0.02 for S218L versus 0.17 ± 0.01 for WT, p = 0.005 by t test; Fig-
ures 4D and 7D). BHQ had a larger effect in enhancing ICa at the
end of the train in S218L compared to WT channels (FBHQ =
1.06 ± 0.01 for S218L at 0.1 s versus 1.02 ± 0.01 for WT at
0.3 s, p = 0.03 by t test; Figures 4E and 7E) and increased CDF
for S218L (FCDF = 0.15 ± 0.02), such that it was not different
fromWT (FCDF = 0.17 ± 0.01; p = 0.63; Figures 4D and 7D). Taken
together, our findings show that BHQ opposes both the
enhanced activation and limited CDF of S218L in transfected
HEK293T cells.
BHQ Offsets Gain of Function in Synaptic Transmission
due to S218L
To determine if BHQ could offset the neurophysiological deficits
associated with S218L, we turned to the Drosophila neuro-
muscular junction (NMJ) as an in vivo model. Here, as in
mammals, Cav2.1 channels mediate presynaptic Ca
2+ influx
that triggers neurotransmitter release (Kawasaki et al., 2000;
Macleod et al., 2006; Uchitel et al., 1992). Subsequent activation
of postsynaptic ionotropic glutamate receptors depolarizes the
innervated muscle membrane. The resulting excitatory post-
synaptic potentials (EPSPs) scale with the amount of neuro-
transmitter release and promote muscle contraction. Based on
previous reports of enhanced transmission at neuromuscular
synapses of S218L KI mice (Kaja et al., 2010), we predicted a
similar impact of S218L in Drosophila.
To test this, the mutation analogous to S218L was introduced
into the Drosophila ortholog of CACNA1A, cacophony and
transgenically expressed in the Drosophila nervous system
(‘‘S218L’’). The C155-GAL4 (elaV) neuronal driver allowed
expression of the transgene in the presynaptic motor neuron
but not muscle (Lin and Goodman, 1994). Compared to controls
expressing the WT transgene (‘‘WT’’), the amplitude of EPSPs
was significantly greater in NMJs expressing the mutant channel(E) The effect of BHQ was measured as the ratio of Inorm. in the presence
of BHQ to the mean Inorm. under control conditions at 0.3 s (FBHQ; mean ±
SEM). For control, n = 17 for ICa, and n = 8 for IBa; for +BHQ, n = 17 for ICa, and
n = 8 for IBa.
See also Figure S3.
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Figure 5. BHQ Opposes Enhanced Activa-
tion of S218L
(A and B) Current-voltage (A) and normalized tail
IBa voltage (B) relationships for cells transfected
with WT Cav2.1 or S218L. Same voltage protocols
as in Figures 1E and 1F.
(C–H) Same as in Figures 1D–1F and 1H–1J
but for cells transfected with S218L. Points
represent mean ± SEM; n = 12 for IBa, and n = 10
for ICa.
See also Figure S4.
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Modulation of Cav2.1 Gating by BHQ(‘‘S218L’’; Figure 8A). This result was not due to increased
numbers of synaptic boutons in ‘‘S218L’’ versus ‘‘WT,’’ which
were not significantly different between genotypes (Table 2). An-
alyses of quantal content corrected for nonlinear summation and
plotted against different extracellular Ca2+ concentrations
revealed nearly identical Ca2+-cooperativity slope values for
‘‘WT’’ and ‘‘S218L’’ (2.65 and 2.61, respectively). Thus,
increased EPSP amplitudes in ‘‘S218L’’ are likely due to greater
presynaptic Ca2+ currents mediated by ‘‘S218L’’ rather than in-
creases in the Ca2+ cooperativity of neurotransmitter release.
At 5 mM, BHQ caused nearly 50% inhibition of EPSP ampli-
tudes in ‘‘WT’’ NMJs but did not affect miniature EPSP (mEPSP)
amplitudes (Figures 8B and 8C). These results were consistent
with a presynaptic action of BHQ, most likely due to inhibition
of Cav2.1 activation (Figure 1). However, this concentration of96 Neuron 81, 91–102, January 8, 2014 ª2014 Elsevier Inc.BHQ had no effect on EPSP amplitudes
in ‘‘S218L’’ NMJs. At 10 mM, BHQ
strongly inhibited EPSP amplitudes but
also affected mEPSPs in both genotypes
(Figures 8B and 8C). This result sug-
gested an additional effect of BHQ at
higher concentrations on spontaneous
release properties. Therefore, BHQ at
10 mM reversed the gain of function in
synaptic transmission in ‘‘S2l8L’’ NMJs,
although this effect could not be attrib-
uted to actions on Cav2.1 alone.
BHQ Restores Synaptic Plasticity
Defect due to S218L
Short-term facilitation (STF) of synaptic
transmission during bursts of impulses is
a form of synaptic plasticity that can be
driven by the accumulation of presynaptic
Ca2+ (Zucker and Regehr, 2002). At
cerebellar synapses of S218L KI mice,
STF is impaired, which has been attrib-
uted to weak CDF of S218L channels
(Adams et al., 2009). However, a caveat
is that basal release probability is
inversely related to the magnitude of
STF (Zucker and Regehr, 2002). There-
fore, it is also possible that the gain of
function of S218L channels would
increase basal synaptic transmission,which would subsequently suppress STF in S218L KI mice, inde-
pendent of any changes in CDF (Adams et al., 2009). The fact
that BHQ at 5 mM increased CDF of S218L channels in
HEK293T cells (Figure 7), but did not affect evoked release in
‘‘S218L’’ NMJs (Figures 8B and 8C), provided an opportunity
to determine if weak CDF contributes to the synaptic plasticity
defect due to the S218L mutation. If so, this concentration of
BHQ should increase STF of ‘‘S218L’’ NMJs.
To test this prediction, we analyzed trains of EPSPs evoked
by repetitive (10 Hz) stimuli of presynaptic motor neurons. To
improve resolution of STF, we initially maintained extracellular
Ca2+ concentrations at 0.4 mM so as not to saturate the release
machinery and create problems with nonlinear summation. STF
was measured as the amplitude of the evoked EPSPs normal-
ized to that for the initial EPSP of the train (Fratio). Compared to
Figure 6. BHQ Slows Deactivation of S218L More than WT Cav2.1
(A) Representative ICa and IBa obtained from cells transfected with S218L.
Currents were evoked by 15 ms steps to various voltages from80 mV before
(control) and after exposure to BHQ (+BHQ; 10 mM).
(B) For +10mV (ICa) and 0mV (IBa) test pulses, the decay of tail currents evoked
on repolarization to 40 mV was fit with a double exponential function.
Averaged data (mean ± SEM) represent the time constant (t) and fractional
contribution (Fraction) of the fast and slow components. *p < 0.01 by paired
t test; n = 8 for ICa, and n = 12 for IBa.
(C and D) Larger effects of BHQ on deactivation of S218L compared to WT
channels. Representative traces (C) show ICa evoked by +20 mV (WT) and
+10 mV (S218L) test pulses with repolarization to 40 mV before (control) and
after exposure to BHQ (+BHQ; 10 mM). In (D), tslow and Fslow were obtained by
double exponential fits of tail ICa obtained as in (C). Data represent mean ±
SEM. *p < 0.05 by t test; n = 7 for WT, n = 8 for S218L.
Figure 7. BHQ Enhances CDF in S218L
(A–E) Representative ICa and IBa obtained by APWs and analysis are the same
as in Figures 4A–4E but in cells transfected with S218L. n = 10 for ICa, and n = 8
for IBa. *p = 0.003 by paired t test. In (B) and (C), dashed lines indicate level of
Inorm. for ICa of WT channels (Control and +BHQ) in Figures 4B and 4C. In (D),
*p = 0.005 by t test. Data in (B) through (E) represent mean ± SEM.
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Modulation of Cav2.1 Gating by BHQ‘‘WT’’ NMJs [Fratio at 1 s = 1.22 ± 0.09], EPSPs showed signif-
icantly less STF in ‘‘S218L’’-expressing NMJs (Fratio at  1 s =
0.99 ± 0.04; p = 0.01 by t test; Figures 9A and 9B). These resultsconfirm that the synaptic defects that are associated with the
S218L mutation (Kaja et al., 2010; van den Maagdenberg et al.,
2010) are reproduced by the ‘‘S218L’’ at the Drosophila NMJ.
BHQ (5 mM) essentially restored STF in ‘‘S218L’’ NMJs: there
was no significant difference in STF of ‘‘WT’’ controls (Fratio at
1 s = 1.22 ± 0.09) and ‘‘S218L’’ with BHQ (Fratio at 1 s =
1.20 ± 0.10, p = 0.70; Figures 9A–9C). This result is consistent
with the effects of BHQ in enhancing CDF of S218L in
HEK293T cells (Figure 7).Neuron 81, 91–102, January 8, 2014 ª2014 Elsevier Inc. 97
Figure 8. BHQ Reverses Gain of Function in Synaptic Transmission
due to S218L
EPSPs were recorded from muscles of transgenic flies expressing the WT
cacophony (‘‘WT’’) or the channel with mutation corresponding to S218L
(‘‘S218L’’). Extracellular solution contained 0.4 mM Ca2+.
(A) Representative traces for averaged evoked EPSPs (left) and the mean ±
SEM for EPSP amplitudes. *p = 0.013 by t test.
(B) Left shows representative averaged EPSPs overlaid for comparison in
the presence (5 or 10 mM) or absence of BHQ (Control). Right shows mean ±
SEM for EPSP amplitudes.
(C) mEPSP amplitudes measured in ‘‘WT’’ and ‘‘S218L’’ with the indicated
concentrations of BHQ. Data represent mean ± SEM. In (A) through (C),
numbers in parentheses indicate numbers of cells. In (B) and (C), *p < 0.05
compared to no BHQ (control) by one-way ANOVA and post hoc Bonferroni
t test.
Table 2. Synaptic Bouton Counts in ‘‘WT’’ and ‘‘S218L’’ Flies
Genotype Muscle A2 6/7 Muscle A3 6/7
‘‘WT’’ 97.6 ± 3.2 (n = 19) 79.7 ± 4.3 (n = 19)
‘‘S218L’’a 93.0 ± 3.2 (n = 27) 74.5 ± 2.0 (n = 26)
Drosophila larval NMJ fillet preparations were double labeled with anti-
synapsin and anti-Dlg primary antibodies as described in Experimental
Procedures. Synapses for muscle group 6/7 in segments A2 and A3
were examined by immunofluorescence, and synaptic boutons per
NMJ 6/7 were counted. For both muscle segments examined, presynap-
tic expression of ‘‘S218L’’ has no significant effect on synapse growth by
Student’s t test (compared to ‘‘WT,’’ p values indicated). Numbers repre-
sent synapse counts (mean ± SEM; n = number of synapses counted per
genotype).
ap = 0.31 for muscle A2 6/7, and p = 0.28 for muscle A3 6/7.
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decreasing release probability, we performed similar experi-
ments but with a reduced extracellular concentration of Ca2+
(0.2 mM; Figures 9B and 9C). Similar to our results obtained
with 0.4 mM Ca2+, BHQ (5 mM) did not affect the amplitude of
the evoked EPSP in ‘‘S218L’’ NMJs (5.5 ± 0.8 mV for control
versus 5.4 ± 1.2 mV for BHQ; p = 0.97; Figure 9D) but still
restored STF to the level of the ‘‘WT’’ control in 0.2mMCa2+ (Fig-
ures 9B and 9C). This result argues against the likelihood that
BHQ restored STF to ‘‘S218L’’ simply by inhibiting presynaptic
Ca2+ channels and/or release properties. BHQ did seem to98 Neuron 81, 91–102, January 8, 2014 ª2014 Elsevier Inc.enhance the Ca2+ cooperativity of release for ‘‘S218L,’’ but after
normalizing for this effect, BHQ still increased STF to ‘‘WT’’ con-
trol levels (Figure S5). At a physiological extracellular Ca2+ con-
centration (1.5 mM), we observed short-term depression (STD),
as opposed to STF for both ‘‘WT’’ and ‘‘S218L.’’ Despite this dif-
ference, BHQ significantly abated STD at early time points
without affecting evoked EPSP amplitudes (Figures 9D and
9E), consistent with the STF data at lower levels of external
Ca2+. Collectively, our findings support the argument that, by
enhancing CDF, BHQ can promote normal synaptic plasticity
in the context of the S218L mutation.
DISCUSSION
BHQ Is a Cav2.1 Gating Modifier
Divalent cations, toxins, and small molecules have yielded rich
insights into the structure, function, and physiological roles of
Cav channels in excitable cells. Like gating modifiers such as
agatoxin IVA (McDonough et al., 1997), BHQ inhibits the voltage
dependence of Cav2.1 activation in a manner that can account
for the decrease in the steady-state current (Figures 1D–1K).
While agatoxin IVA speeds deactivation of neuronal Cav2.1
channels (McDonough et al., 1997), BHQ has the opposite effect
(Figure 3). In this regard, BHQ is similar to roscovitine—an inhib-
itor of cyclin-dependent kinases that also slows deactivation of
Cav2.1 and Cav2.2 channels (Buraei et al., 2005; Yan et al.,
2002). At higher concentrations that involve a kinase-dependent
mechanism, roscovitine also inhibits Cav2.2 (Buraei et al., 2005).
In contrast, our results indicate that the opposing effects of BHQ
on activation and deactivation are mechanistically linked. These
modulatory effects may have been missed in previous studies
due to the use of high concentrations of BHQ (>100 mM; Fusi
et al., 2001; Scamps et al., 2000) that strongly depress current
amplitudes (Figure 1B). The dual agonist and antagonist actions
of BHQare unique among substances that modulate Cav2.1, and
should prove useful in mechanistic inquiries into the complex
gating properties of these channels.
Modulation of CDF by BHQ: Insights into an Aspect of
S218L Gain of Function
During trains of APWs, ICa in HEK293T cells transfected with
Cav2.1 may undergo VDF, perhaps due to relief from G-protein
Figure 9. BHQ Restores STF to S218L at 5 mM
(A) Traces represent averaged EPSPs evoked by 10 Hz stimulation. Vertical
bars represent 20 mV each.
(B) STF measured as averaged EPSP amplitudes normalized to the first in the
series (Fratio) and plotted against timewith extracellular (Ca
2+) at 0.4mM (left) or
0.2 mM (right). Points represent mean ± SEM.
(C) Graphs represent STF at 1 s (Fratio,1 s, mean ± SEM)measured from the data
in (B). The p values shown were determined by Mann-Whitney rank sum test.
Parentheses indicate numbers of cells.
(D) At the indicated concentrations of extracellular Ca2+, basal evoked EPSP
amplitudes (mean ± SEM) were compared for control and BHQ in ‘‘WT’’ (left)
and ‘‘S218L’’ (right). *p < 0.05 by t test.
(E) Same as in (B) except that extracellular Ca2+ was 1.5mM. *p < 0.05 by t test.
See also Figure S5.
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Modulation of Cav2.1 Gating by BHQinhibition (Brody et al., 1997), and CDF (Chaudhuri et al., 2007)
due to Ca2+/CaM binding to the C-terminal domain of the
Cav2.1 a1 subunit (DeMaria et al., 2001; Lee et al., 1999, 2000).
Elementary analyses indicate that both Ca2+/CaM and G
proteins may stimulate transitions to a gating mode of higher
open probability (Po), but via distinct biophysical pathways
(Chaudhuri et al., 2007; Colecraft et al., 2001). Assuming that
VDF and CDF are mechanistically separable gating modes, the
inhibition of VDF by BHQ may increase the availability of WT
Cav2.1 channels to undergo CDF (Figure 4E). An alternate,
although not mutually exclusive, explanation is suggested by
the effects of BHQ on the S218L mutant. It has been proposed
that the hyperpolarized shift in the voltage dependence of activa-
tion of S218L may cause these channels to be ‘‘prefacilitated,’’
so that they are not sensitive to Ca2+/CaM-stimulated transitions
to the high Po gating mode (Adams et al., 2010). By inhibiting
voltage-dependent activation (Figure 5H; Table 1), BHQ may re-
turn a fraction of themutant channels to the normal low Po gating
mode so they can undergo CDF. An understanding of the mech-
anistic basis for howBHQmodulates CDF awaits detailed single-
channel analyses of ICa and IBa in WT and S218L channels.
In the absence of BHQ, we identified a slow component of
deactivation that was significantly greater for ICa mediated by
S218L compared to WT channels (Figure 6D). Because CDF is
associated with a broadening of tail ICa during APW trains
(Chaudhuri et al., 2007), this difference may arise from the ‘‘pre-
facilitated’’ S218L channels. Although not noted previously, the
50% increase in the slow tail ICa in S218L compared to WT
channels (Figure 6D) would augment action-potential-driven
neurotransmitter release and subsequently accelerate the
development of synaptic depression. Indeed, compared to
WT, EPSPs at the NMJ in S218L KI mice are of greater amplitude
and show faster rundown at physiological firing frequency (Kaja
et al., 2010). Moreover, EPSPs at S218L KI NMJ are broader than
in WT and often exhibit an irregular plateau during the falling
phase (Kaja et al., 2010). These results could be explained by
the increased slow deactivation of S218L channels, which
may cause abnormal prolongation of neurotransmitter release.
Similar alterations in S218L deactivation at central synapses
may contribute to the increased excitatory transmission and
lower thresholds for cortical spreading depression, which is
thought to underlie the headache symptoms associated with
migraine (van den Maagdenberg et al., 2010).
Dysregulation of CDF and Impaired Synaptic Plasticity
Caused by S218L
CDF of presynaptic Cav2.1 channels has emerged as an impor-
tant determinant of STF (Mochida et al., 2008). At the parallel
fiber-Purkinje cell synapse, STF is robust in WT but not in
S218L KI mice (Adams et al., 2010), which could be explained
by reduced net CDF caused by the S218L mutation. However,
a complicating factor is that increased Ca2+ influx in parallel fiber
terminals due to ‘‘prefacilitated’’ channels (Adams et al., 2010)
would likely saturate the Ca2+ sensor for exocytosis in S218L
KI mice. This would decrease release probability, which itself
would reduce STF. Our findings that BHQ restores not only
CDF of S218L channels in HEK293T cells (Figure 7) but also
STF at ‘‘S218L’’ NMJs (Figure 9) indicate that dysregulation ofNeuron 81, 91–102, January 8, 2014 ª2014 Elsevier Inc. 99
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Modulation of Cav2.1 Gating by BHQCDF contributes to the impaired synaptic plasticity caused by
the S218L mutation. Given the localization of Cav2.1 channels
at most central synapses (Westenbroek et al., 1995), our results
predict widespread deficits in short-term plasticity caused by
the S218L mutation. Whether such alterations contribute to the
neurological phenotypes associated with FHM-1 remains an
important challenge for future studies.Therapeutic Implications for Cav2.1 Channelopathies
The CACNA1A gene encoding Cav2.1 channels is a major target
of mutations that cause severe neurological disorders in humans
(Pietrobon, 2010). Significant advances have been made in
understanding the pathogenic mechanisms associated with
some of the mutations, thanks to the generation of appropriate
KI mice (van den Maagdenberg et al., 2004, 2010; Watase
et al., 2008). Our study highlights the use of Drosophila as an
alternate strategy to investigate the synaptic defects caused
by CACNA1A mutations. The gain of function in EPSPs and
impaired STF at the NMJs of ‘‘S218L’’-expressing flies (Figures
8 and 9) are similar to that seen at the NMJs and parallel fiber-
Purkinje cell synapses, respectively, of S218L KI mice (Adams
et al., 2010; Kaja et al., 2010). Moreover, BHQ regulates synaptic
transmission at ‘‘WT’’ and ‘‘S218L’’ NMJs in amanner consistent
with its modulation of the corresponding channels in HEK293T
cells. These results indicate that the incorporation of human mu-
tations into the cacophony gene, and expression of the mutant
construct in Drosophila motor neurons, can simulate the func-
tional abnormalities associated with Cav2.1 channelopathies.
This approach should prove useful in the search for pharmaco-
logical and genetic modifiers that can ameliorate the often se-
vere neurophysiological consequences of CACNA1Amutations.
Despite the known activity of BHQ on SERCAs and Cav chan-
nels (Fusi et al., 2001; Moore et al., 1987; Scamps et al., 2000),
the effects of BHQ on synaptic transmission at the Drosophila
NMJ could be explained largely by its modulation of Cav2.1.
Due to its pro-oxidant effects and actions on targets other than
Cav2.1, BHQ itself may not be therapeutically suitable as a
specific gating modifier for neuronal Cav2.1 channels. However,
the ability of BHQ to oppose the defects in Cav2.1 gating and
synaptic transmission associated with the S218L mutation
suggests that modification of the chemical structure of BHQ
may yield small-molecule modulators that could selectively
inhibit or enhance activation/deactivation gating of Cav2.1.
Such compounds would greatly extend current capabilities to
dissect the functions of Cav2.1 channels in normal and diseased
states of the nervous system.EXPERIMENTAL PROCEDURES
Cell Culture and Transfection
The following Cav subunit cDNAs were used: human WT a12.1 (GenBank
accession number NM_023035.1) or S218L mutant in pcDNA 3.1 Zeo (+)
(generously provided by Dr. T. Snutch, described in Adams et al., 2010), rat
b2a (GenBank accession number NM_053851), and rabbit a2d1 (GenBank
accession number M21948). HEK293T cells were maintained in Dulbecco’s
modified Eagle’s medium with 10% fetal bovine serum (Life Technologies),
penicillin (50 U/ml), and streptomycin (50 mg/ml) at 37C in a humidified atmo-
sphere with 5% CO2. Cells were grown to 80% confluency and transfected
with Fugene 6 (Roche) according to the manufacturer’s protocol. Cells were100 Neuron 81, 91–102, January 8, 2014 ª2014 Elsevier Inc.transfected with cDNAs encoding WT-a12.1 or S218L- a12.1 (1 mg), b2a
(0.5 mg), and a2d1 (0.5 mg) with pEGFP-N1 (Life Technologies, 0.1 mg).
Electrophysiological Recordings of Transfected HEK293T Cells
Ca2+ or Ba2+ currents were recorded in transfected HEK293T cells in whole-
cell patch-clamp configuration at room temperature. Recordings were per-
formed between 48 to 72 hr after transfection. Extracellular recording solutions
contained 150mM Tris, 1 mMMgCl2, and 10mMCaCl2 or 10mMBaCl2. Intra-
cellular recording solutions contained 140 mMN-methyl-D-glucamine, 10 mM
HEPES, 2 mMMgCl2, 2 mMMg-ATP, and 5 mM EGTA. The pH of extracellular
and intracellular recording solutions were adjusted to 7.3 withmethanesulfonic
acid. Reagents used for electrophysiological recordings were obtained from
Sigma-Aldrich. BHQ (Tocris Bioscience) was dissolved in DMSO at a concen-
tration of 100mM tomake a stock solution. BHQwas diluted with the extracel-
lular solution immediately before recording. For each cell, voltage protocols
were run first under control conditions (0.01%DMSO) followed by extracellular
perfusion with BHQ and finally on washout of BHQ with the control solution.
Data from cells in which the effect of BHQ was reversible were included in
the analysis.
Recording electrodeswere pulled fromborosilicate glass (World Precision In-
struments) on a Sutter P97 puller (Sutter Instruments). Electrode resistances in
the recording solutions were typically 2–4 MU. Series resistance ranged from
4 to 6 MU and compensated at 50%–80%. Currents were recorded with an
EPC-10 patch-clamp amplifier driven by PatchMaster software (HEKA Elec-
tronics). Leak current was subtracted using a P/8 protocol. Whole-cell currents
weredigitizedat 50kHzafter filteringat 10kHz.APWswereconstructedbyaver-
aging traces corresponding to spontaneous action potentials recorded in cur-
rent clamp from dissociated mouse Purkinje neurons (Kreiner et al., 2010).
Data were analyzed using routines written in IGOR Pro software (WaveMetrics).
Averaged data represent the mean ± SEM. Statistical differences between
groupswere determined byStudent’s t test unless otherwise indicated. Tail cur-
rent-voltage relationshipswere fitwith a singleBoltzmann function, (I /{1+ exp[
(V Vh)/k] + b}), or double Boltzmann function, I1 /{1 + exp[ (V Vh1)/k1]} + I2/
{1 + exp[ (V Vh2)/k2] + b}, where I is themaximal current, V is the test voltage,
Vh is the voltageof half-activation, k is the slope factor, andb is thebaseline.Due
to the complicating effects of CDF, tail ICa voltage curves under control condi-
tions were fit through themaximum ICa (usually obtained at 30–40mV). Tail cur-
rent decay kinetics were fit with a single exponential function, y0 + {A1 , exp[
(t  t0)/t1]}, or a double exponential function, y0 + {A1 , exp[ (t  t0)/t1]} +
{A2 , exp[ (t  t0)/t2]}, where y0 is the baseline, t is time, t0 is initial time, and
A is amplitude. The decay was fit over an interval long enough for the current
to reach steady state in control and in the presence of BHQ. In comparisons
of ICa and IBa evokedby single test pulses, results are compared at different volt-
ages to account for the differences in voltage-dependent activation due to
distinct surface charge screening effects of Ca2+ and Ba2+ (see Vh in Table 1).
Measurements of Intracellular Ca2+ Concentration
Transfected HEK293T cells were either incubated with Fura-2/AM or loaded
with Fura-2 (Invitrogen) via the patch pipette (100 mM), which also contained
the intracellular recording solution described for electrophysiological record-
ings. Cells were placed in a flowthrough chamber mounted on the stage of
an inverted IX-71 microscope (Olympus). Fluorescence was alternately
excited at 340 (12 nmbandpass) and 380 (12 nm bandpass) nm using the Poly-
chrome IV monochromator (TILL Photonics) via a 403 oil-immersion objective
(NA = 1.35, Olympus). Emitted fluorescence was collected at 510 nm (80 nm
bandwidth) using an IMAGO CCD camera (TILL Photonics). Pairs of 340/
380 nm images were sampled at 10 Hz. Fluorescence was corrected for
background, as determined in an area that did not contain a cell. Data were
processed using TILLvisION 4.0.1.2 (TILL Photonics) and presented as a fluo-
rescence ratio of F340/F380, where F340 and F380 are fluorescence intensities at
the excitation wavelengths 340 and 380 nm, respectively.
Electrophysiological Recordings of Drosophila NMJ
The cacophony transgenic lineUAS-cac-EGFP786c (Kawasaki et al., 2004) was
expressed under control of the C155-GAL4 (elaV) driver (Lin and Goodman,
1994) as the ‘‘WT’’ condition. For the ‘‘S218L’’ condition, we used PCR to
mutate the serine 161 codon in the UAS-cac-EGFP cDNA analogous to serine
Neuron
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generate a UAS-cac-EGFPS/L transgene and expressed using the same
C155-GAL4 driver.
For electrophysiological recordings of NMJs, wandering third instar larvae
were selected for analysis. Sharp electrode recordings were taken from
muscle 6 of abdominal segments 2 and 3, as described elsewhere (Davis
et al., 1998; Frank et al., 2006, 2009). Larvae were dissected in a modified HL3
saline with the following components (and concentrations): NaCl (70 mM), KCl
(5 mM), MgCl2 (10mM), NaHCO3 (10mM), sucrose (115mM= 3.9%), trehalose
(4.2 mM = 0.16%), HEPES (5.0 mM= 0.12%), and CaCl2 (0.4 mM, unless other-
wise indicated).DatawerecollectedusinganAxopatch200Belectrodeamplifier
(Molecular Devices), digitized using a Digidata 1440A data acquisition system
(Molecular Devices), and recorded with pCLAMP 10 acquisition software (Mo-
lecular Devices). For presynaptic nerve stimulation, a Master-8 pulse stimulator
(A.M.P. Instruments) and an ISO-Flex isolation unit (A.M.P. Instruments) were
utilized to deliver stimuli to the nerve (1-ms stimulus duration).
A custom function was written in Igor Pro for amplitude analysis of trains
of EPSPs evoked at the NMJ. For each EPSP, a single exponential was
used to fit the decay of the EPSP peak to the start of the next EPSP. The expo-
nential decay was then extrapolated to the time point of the subsequent peak
response. This point was used as the baseline for peak amplitude measure-
ments of EPSPs 2–50. The first EPSP peak amplitude was simply the baseline
measured before the train subtracted from the first peak. Two to four trains
were evoked per muscle. The EPSP amplitudes measured by the aforemen-
tioned procedure were then averaged. These averaged amplitudes were
then normalized to the first averaged EPSP amplitude to yield Fratio values
for each muscle so that the SE for Fratio plotted in Figure 9 represents the vari-
ability between muscles. Averaged data represent mean ± SEM from four to
six animals per genotype.
NMJ Analyses by Immunocytochemistry
Dissected third instar larvae were fixed for 2–4 min in Bouin’s fixative (Ricca
Chemical Company or Sigma-Aldrich), washed with PBS and PBS + 0.1%
Tween-20 (PBT), and incubated overnight at 4Cwith primary antibodies. After
three washes in PBT, secondary antibodies were applied for 2 hr at room tem-
perature. The following primary antibodies were used: mouse anti-Synapsin,
1:50 (Developmental Studies Hybridoma Bank [DSHB], University of Iowa;
Klagges et al., 1996), mouse anti-Bruchpilot, 1:250 (DSHB; Wagh et al.,
2006), rabbit anti-GluRIIC, 1:3,000 (Marrus and DiAntonio, 2004), and rabbit
anti-Dlg, 1:3,000 (Budnik et al., 1996). Fluorophore-conjugated goat anti-
mouse and goat anti-rabbit secondary antibodies were used (Jackson Immu-
noresearch Laboratories).
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